Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tokyo High Court Reaches Settlement With 21 Hepatitis C Victims 

This article was originally published in PharmAsia News

Executive Summary

Following similar high court settlements with hepatitis C victims in Osaka and Fukuoka, Tokyo high court judge, Katsuya Kobayashi, announced a settlement with 21 plaintiffs on Feb. 29. The government will take responsibility for the infections caused by tainted blood products and pay ¥476 million to the victims. The victims will receive ¥40 million, ¥20 million and ¥12 million in compensation, respectively, according to the seriousness of symptoms. The Tokyo settlement adds to a total of 87 settled cases. Attorneys representing the hepatitis C victims also said that negotiations with pharmaceutical companies for a settlement are ongoing. (Click for more-Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067955

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel